ProstaMate
ProstaMate, licence 80028717: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- FreeLife International Canada Corp.
- NPN or DIN-HM
- 80028717
- Status
- Inactive licence
- Licence date
- 20 December 2011
- Revision date
- Not provided
- Form
- Caplet
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boron Source : Produit de chélation de bore et de protéine animale hydrolysée (PAH) Extraction ratio : 4:1 Dry plant equivalent : 250 mg | 350.0 mcg | Not calculated |
| Boswellia serrata Source : Extrait de résine Extraction ratio : 10:1 Dry plant equivalent : 1050 mg | 105.0 mg | Not calculated |
| Urtica dioica Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 250 mg | 62.5 mg | Not calculated |
| Cucurbita pepo Source : Graine(s) Extraction ratio : 4:1 Dry plant equivalent : 250 mg | 62.5 mg | Not calculated |
| phytostérols Potency : 40.0 % beta sitosterol | 162.5 mg | Not calculated |
| Lycium barbarum Source : Fruit(s) Extraction ratio : 5:1 Dry plant equivalent : 5 mg | 1.0 mg | Not calculated |
Non-medicinal ingredients
Amidon de maïs, Microcrystalline cellulose, Silice, Croscarmellose de sodium, Modified food starch, Stéarate de magnésium, Acide stéarique, Glucose, dl-alpha tocophérol, ascorbate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Caplet | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain good health. Helps in the development and maintenance of bones and teeth. Calcium intake, when combined with sufficient vitamin D, a healthy diet and regular exercise, may reduce the risk of developing osteoporosis. Helps in connective tissue formation. Helps to maintain healthy skin. Helps the body to metabolize carbohydrates, fats and proteins. Helps to maintain immune function. Used in Herbal Medicine to help reduce difficulty in urination (e.g. weak urine flow, incomplete voiding, frequent daytime and night rime urination) associated with the early stages of benign prostatic hyperplasia (BPH).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80028717
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.